Xconomy National

Archives

by in

Entry	Author	Date	Location
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects	Arlene Weintraub	02/06/12	National
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic	Luke Timmerman	01/31/12	San Diego
Four Themes to Watch in Personalized Medicine	Jonathan Sheffi	01/30/12	San Francisco
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting	Luke Timmerman	01/23/12	National
Report: UCSF Chancellor Proposes Autonomy in State University System	Luke Timmerman	01/20/12	San Francisco
Clarus Ventures Adjusts to Unpredictable Biotech World	Luke Timmerman	01/20/12	Boston
J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’	Luke Timmerman	01/18/12	San Diego
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership	Luke Timmerman	01/17/12	San Francisco
Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes	Luke Timmerman	01/09/12	Boston
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls	Luke Timmerman	01/03/12	Boston
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011	Gregory T. Huang	12/28/11	Boston
MIT-Born Enumeral Advances Human-Based Method for Hunting Drugs	Arlene Weintraub	12/20/11	New York
Trius Antibiotic Passes Pivotal Study Against Pfizer’s Zyvox	Luke Timmerman	12/19/11	San Diego
AesRx Navigates “Valley of Death” to Get Sickle Cell Drug Into Trials	Arlene Weintraub	12/14/11	Boston
Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of	Luke Timmerman	12/13/11	Boston
Lpath Looks to Raise $10 Million Through Secondary Offering	Bruce V. Bigelow	12/08/11	San Diego
Buyouts, Quantified Health, & More San Diego Life Sciences News	Bruce V. Bigelow	12/01/11	San Diego
MSU Bioeconomy Institute Snags State and Federal Funding For Proof of Concept Center	Sarah Schmid	11/29/11	Detroit
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring	Luke Timmerman	11/22/11	San Diego
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News	Bruce V. Bigelow	11/10/11	San Diego
The Stroke Prevention War is On: FDA Approves J&J/Bayer Contender	Arlene Weintraub	11/07/11	New York
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011	Luke Timmerman	11/07/11	National
Sanford-Burnham Joins Fold at Pfizer’s Centers for Therapeutic Innovation	Bruce V. Bigelow	11/03/11	San Diego
Biopharma Industry Meetings Could Use Some Fresh Voices	Stewart Lyman	11/01/11	Seattle
The Cancer Drug Dark Ages Are Coming to an End	Luke Timmerman	10/31/11	National
Illumina Leads $8M Investment in GenoLogics to Help Manage DNA Data Overload	Luke Timmerman	10/20/11	Seattle
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes	Luke Timmerman	10/18/11	San Francisco
Computers vs. Humans: A Recap of Xconomy’s New York Life Sciences 2031	Arlene Weintraub	10/14/11	New York
Join Xconomy Tonight for New York Life Sciences 2031	Arlene Weintraub	10/13/11	New York
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News	Luke Timmerman	10/13/11	Seattle
Page 1 of 13	next page »